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The magnitude of underdosage depends on the TSA size (see 
table below). The maximum underdosage (0 cm of solid 
water above flap) generally increases with increasing TSA 
size. However the sensitivity of the TSA to the initial 
reduction of scatter is greatest for the smallest TSA.  
 
 
 
Conclusions: Analysis of the results of this project is still 
ongoing. Considering AAPM recommends a dose calculation 
accuracy of ±2% and a dose delivery accuracy of 5-10% [Nath 
1997] in brachytherapy the underdosage observed is not 
trivial. It is suggested that the underdosage could be 
accounted for during the treatment planning process either 
by increasing the surface dose or by the addition of bolus.  
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Purpose/Objective: Since the past years, the evolution of 
brachytherapy techniques was unique. The main advances 
arise from many features, such as: new dose delivering 
techniques, accuracy in the absorbed dose calculations, 
optimized accessories for implants and patient quality 
assurance, and development of new radioactive sources. The 
Energetic and Nuclear Research Institute (IPEN-CNEN/SP), 
with the main radiotherapy centers in Brazil, created a new 
LDR 192Ir to be used for ocular, prostate and cerebral tumors 
in the low dose rate (LDR) range. The new 192Ir LDR source 
has a cylindrical geometry (3.0 mm and 4.5 mm for outer 
diameter and length, respectively), suitable for accessories 
and holders existent in the market. Since the dosimetric 
characteristics are fundamental for patient dose planning 
accuracy. 
This work evaluate the dosimetric parameters of a new LDR 
brachytherapy 192Ir source using Monte Carlo simulations. 
Materials and Methods: The dosimetric functions were 
obtained using the PENELOPE/penEasy 2008 Monte Carlo 
source code, using the track-length estimator due to the low 
energy of the 192Ir photons. All the dosimetric parameters 
used in this work were based in the American Association 
Physics in Medicine (AAPM) Task Group-43 (TG43). To 
separated simulations runs, with the source in air and liquid 
water phantom, were performed to calculate the air-kerma 
strength (Sk) and water-based dosimetric factors. 
Comparisons of the new 192Ir LDR source dosimetric 
parameters were also made with similar source in the 
market. Uncertainty analysis was computed to estimate the 
statistical variations of the simulated dosimetric data.  
Results: The simulations results provide analogous values 
with LDR brachytherapy sources, for the same energy range. 
The constant dose-rate (L) was 1.11± 0.01 cGy.(hU)-1, 0.5% 
different from a 192Ir LDR source (Best Industries, VA – USA) 
available in the market. Anisotropy functions for the new 192Ir 
LDR sources are slightly steep in few millimeters around the 
source tips, this effect is expected because the encapsulation 
is thicker in these regions than in the wall. Radial dose 
functions were higher around 4.0 cm from the center of 
source (transversal axis), this property shows the possibility 
to use this LDR source for deeper tumors, since the similar 
sources has the maximum radial dose function around 3.0 cm. 
Conclusions: The dosimetric parameters for new 192Ir LDR 
brachytherapy source were calculated using AAPM TG-43. Our 
results suggest that this source has dosimetric characteristics 
comparable with similar LDR commercial sources.  
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